CNO
Undervalued by 147.7% based on the discounted cash flow analysis.
Market cap | $3.79 Billion |
---|---|
Enterprise Value | $7.17 Billion |
Dividend Yield | $0.65 (1.69845832244578%) |
Earnings per Share | $3.81 |
Beta | 0.9 |
Outstanding Shares | 100,743,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 12.62 |
---|---|
PEG | -14.38 |
Price to Sales | 0.91 |
Price to Book Ratio | 1.53 |
Enterprise Value to Revenue | 1.67 |
Enterprise Value to EBIT | 23.17 |
Enterprise Value to Net Income | 23 |
Total Debt to Enterprise | 0.61 |
Debt to Equity | 1.74 |
No data
No data